Trial Identifier: | D1346C00004 |
Sponsor: | AstraZeneca |
Collaborator: |
Merck Sharp & Dohme Corp.
|
NCTID:: | NCT05309668 |
Start Date: | January 2022 |
Primary Completion Date: | April 2024 |
Study Completion Date: | February 2028 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Germany | Berlin, Germany, 13353 |
Germany | Hamburg, Germany, 20246 |
Germany | Munchen, Germany, 80337 |
Germany | Tubingen, Germany, 72076 |
Netherlands | Rotterdam, Netherlands, 3015 GD |
Russia | Moscow, Russia, 125412 |
Russia | Moscow, Russia, 119620 |
Spain | Barcelona, Spain, 08950 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |